Calton & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Calton & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-365	Closed	-$243K	–	408
2021 Q4	$243K	Sell	365 -41	-10%	-$25.6K	0.06%	311
2021 Q3	$232K	Sell	406 -232	-36%	-$127K	0.05%	348
2021 Q2	$323K	Buy	638 +81	+15%	+$38.2K	0.06%	288
2021 Q1	$254K	Buy	557 +44	+9%	+$21K	0.05%	313
2020 Q4	$239K	Sell	513 -34	-6%	-$15.9K	0.04%	317
2020 Q3	$242K	Buy	+547	New	+$226K	0.05%	276
2020 Q1	–	Sell	-666	Closed	-$216K	–	379
2019 Q4	$216K	Buy	+666	New	+$202K	0.04%	324
2018 Q1	–	Sell	-15	Closed	-$3K	–	1185
2017 Q4	$3K	Buy	+15	New	+$2.87K	﹤0.01%	1355

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Calton & Associates's TMO Position: Q1 2022 in Review

Calton & Associates sold out of Thermo Fisher Scientific (TMO) in Q1 2022, closing a stake of 365 shares — an estimated $243K sold.

Calton & Associates first reported a position in TMO in Q4 2017 and held it in 8 quarters. The position peaked at $323K in Q2 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

Calton & Associates reported no remaining Thermo Fisher Scientific position as of Q1 2022 after selling out during the quarter.
Calton & Associates sold 365 Thermo Fisher Scientific shares in Q1 2022, an estimated $243K.
Calton & Associates first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 8 quarters.
Calton & Associates's Thermo Fisher Scientific position peaked at $323K in Q2 2021.
2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Calton & Associates's 13F filing for Q1 2022, filed 12 Apr 2022.